RAYTECH HOLDING LTD (RAY)

VGG7385S1011 - Common Stock

1.24  +0.03 (+2.48%)

After market: 1.2 -0.04 (-3.23%)

Fundamental Rating

6

Taking everything into account, RAY scores 6 out of 10 in our fundamental rating. RAY was compared to 15 industry peers in the Distributors industry. While RAY has a great health rating, its profitability is only average at the moment. RAY has a decent growth rate and is not valued too expensively.



6

1. Profitability

1.1 Basic Checks

RAY had positive earnings in the past year.
RAY had a positive operating cash flow in the past year.

1.2 Ratios

The Return On Assets of RAY (28.14%) is better than 100.00% of its industry peers.
RAY has a better Return On Equity (52.63%) than 92.86% of its industry peers.
RAY has a Return On Invested Capital of 47.78%. This is amongst the best in the industry. RAY outperforms 92.86% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for RAY is significantly above the industry average of 21.97%.
The 3 year average ROIC (38.47%) for RAY is below the current ROIC(47.78%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 28.14%
ROE 52.63%
ROIC 47.78%
ROA(3y)27.12%
ROA(5y)N/A
ROE(3y)41.78%
ROE(5y)N/A
ROIC(3y)38.47%
ROIC(5y)N/A

1.3 Margins

Looking at the Profit Margin, with a value of 16.36%, RAY belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Profit Margin of RAY has declined.
RAY has a better Operating Margin (18.32%) than 100.00% of its industry peers.
In the last couple of years the Operating Margin of RAY has declined.
With a Gross Margin value of 23.62%, RAY perfoms like the industry average, outperforming 42.86% of the companies in the same industry.
In the last couple of years the Gross Margin of RAY has declined.
Industry RankSector Rank
OM 18.32%
PM (TTM) 16.36%
GM 23.62%
OM growth 3Y-7.01%
OM growth 5YN/A
PM growth 3Y-5.63%
PM growth 5YN/A
GM growth 3Y-3.56%
GM growth 5YN/A

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so RAY is creating value.
The number of shares outstanding for RAY has been reduced compared to 1 year ago.
RAY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 7.81 indicates that RAY is not in any danger for bankruptcy at the moment.
RAY's Altman-Z score of 7.81 is amongst the best of the industry. RAY outperforms 92.86% of its industry peers.
RAY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 7.81
ROIC/WACC3.61
WACC13.25%

2.3 Liquidity

A Current Ratio of 1.95 indicates that RAY should not have too much problems paying its short term obligations.
The Current ratio of RAY (1.95) is comparable to the rest of the industry.
RAY has a Quick Ratio of 1.89. This is a normal value and indicates that RAY is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of RAY (1.89) is better than 85.71% of its industry peers.
Industry RankSector Rank
Current Ratio 1.95
Quick Ratio 1.89

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 109.83% over the past year.
RAY shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 24.56% yearly.
The Revenue has grown by 56.28% in the past year. This is a very strong growth!
RAY shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 28.10% yearly.
EPS 1Y (TTM)109.83%
EPS 3Y24.56%
EPS 5YN/A
EPS Q2Q%72.71%
Revenue 1Y (TTM)56.28%
Revenue growth 3Y28.1%
Revenue growth 5YN/A
Sales Q2Q%47.13%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 9.54 indicates a reasonable valuation of RAY.
Based on the Price/Earnings ratio, RAY is valued cheaply inside the industry as 85.71% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.28. RAY is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 9.54
Fwd PE N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, RAY is valued cheaper than 85.71% of the companies in the same industry.
RAY's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 9.22
EV/EBITDA 7.32

4.3 Compensation for Growth

RAY has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

RAY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

RAYTECH HOLDING LTD

NASDAQ:RAY (1/14/2025, 8:01:55 PM)

After market: 1.2 -0.04 (-3.23%)

1.24

+0.03 (+2.48%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryDistributors
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners77.22%
Ins Owner ChangeN/A
Market Cap21.84M
AnalystsN/A
Price TargetN/A
Short Float %6%
Short Ratio1.21
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 9.54
Fwd PE N/A
P/S 1.7
P/FCF 9.22
P/OCF 9.22
P/B 5.47
P/tB 5.47
EV/EBITDA 7.32
EPS(TTM)0.13
EY10.48%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.13
FCFY10.85%
OCF(TTM)0.13
OCFY10.85%
SpS0.73
BVpS0.23
TBVpS0.23
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 28.14%
ROE 52.63%
ROCE 58.95%
ROIC 47.78%
ROICexc N/A
ROICexgc N/A
OM 18.32%
PM (TTM) 16.36%
GM 23.62%
FCFM 18.45%
ROA(3y)27.12%
ROA(5y)N/A
ROE(3y)41.78%
ROE(5y)N/A
ROIC(3y)38.47%
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)47.47%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-7.01%
OM growth 5YN/A
PM growth 3Y-5.63%
PM growth 5YN/A
GM growth 3Y-3.56%
GM growth 5YN/A
F-Score5
Asset Turnover1.72
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage 250
Cash Conversion 100.67%
Profit Quality 112.79%
Current Ratio 1.95
Quick Ratio 1.89
Altman-Z 7.81
F-Score5
WACC13.25%
ROIC/WACC3.61
Cap/Depr(3y)19.09%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.01%
Cap/Sales(5y)N/A
Profit Quality(3y)148.96%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)109.83%
EPS 3Y24.56%
EPS 5YN/A
EPS Q2Q%72.71%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)56.28%
Revenue growth 3Y28.1%
Revenue growth 5YN/A
Sales Q2Q%47.13%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y91.4%
EBIT growth 3Y19.12%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y68.28%
FCF growth 3Y40.34%
FCF growth 5YN/A
OCF growth 1Y68.28%
OCF growth 3Y40.19%
OCF growth 5YN/A